THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptorsS P H Alexander, Tung M. Fong, Ross A. D. Bathgate et al.|British Journal of Pharmacology|2021Cited by 488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptorsS P H Alexander, Satoru Eguchi, Arthur Christopoulos et al.|British Journal of Pharmacology|2023Cited by 390
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclatureThomas Günther, Stefan Schulz, Giovanni Tulipano et al.|Pharmacological Reviews|2018Cited by 251
Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic ApproachesKjell Öberg, Bertram Wiedenmann, Oriol Casanovas et al.|Clinical Cancer Research|2013Cited by 89
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors‐Pérez, Justo P. Castaño|Journal of Experimental & Clinical Cancer Research|2021Cited by 58